Works matching AU Niu, Xiaoshuang

Results: 27

Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.

Published in:

2013

By:

Xiaoshuang Niu;
Xi Chang;
Yunsheng Gao;
Chaosu Hu;
Lin Kong;
Niu, Xiaoshuang;
Chang, Xi;
Gao, Yunsheng;
Hu, Chaosu;
Kong, Lin

Publication type:

journal article

Peptide drugs: a new direction in cancer immunotherapy.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 3, p. 198, doi. 10.20892/j.issn.2095-3941.2023.0297

By:

Xinghua Sui;
Xiaoshuang Niu;
Xiuman Zhou;
Yanfeng Gao

Publication type:

Article

Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy.

Published in:

SCIENCE CHINA Life Sciences, 2023, v. 66, n. 10, p. 2310, doi. 10.1007/s11427-022-2285-6

By:

Hu, Zheng;
Li, Wanqiong;
Chen, Shaomeng;
Chen, Danhong;
Xu, Ran;
Zheng, Danlu;
Yang, Xin;
Li, Shuzhen;
Zhou, Xiuman;
Niu, Xiaoshuang;
Xiao, Youmei;
He, Zhuoying;
Li, Huihao;
Liu, Juan;
Sui, Xinghua;
Gao, Yanfeng

Publication type:

Article

Peroxidase‐Like Nanozyme Activates the cGAS‐STING Pathway via ROS‐Induced mtDNA Release for Cancer Immunotherapy.

Published in:

Advanced Functional Materials, 2024, v. 34, n. 39, p. 1, doi. 10.1002/adfm.202401576

By:

Zhu, Xueqin;
Wang, Xiaoxi;
Liu, Zimai;
Jiang, Bing;
He, Zonghong;
Liu, Sijia;
Wu, Yahong;
Wu, Zixian;
Zhang, Tiantian;
Liu, Meiyi;
Li, Kai;
Niu, Xiaoshuang;
Gao, Yanfeng

Publication type:

Article

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy.

Published in:

Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-56648-6

By:

Xiao, Youmei;
He, Zhuoying;
Li, Wanqiong;
Chen, Danhong;
Niu, Xiaoshuang;
Yang, Xin;
Zeng, Wenxuan;
Wang, Mengfan;
Qian, Yuzhen;
Su, Ye;
Luo, Feiyu;
Chen, Guanyu;
Liu, Juan;
Sui, Xinghua;
Zhou, Xiuman;
Gao, Yanfeng

Publication type:

Article

β-Catenin is important for cancer stem cell generation and tumorigenic activity in nasopharyngeal carcinoma.

Published in:

Acta Biochimica et Biophysica Sinica, 2016, v. 48, n. 3, p. 229, doi. 10.1093/abbs/gmv134

By:

Rui Jiang;
Xiaoshuang Niu;
Yuxiang Huang;
Xiaosheng Wang

Publication type:

Article

Self‐assembled Palmitic Acid‐modified Thymopentin Functions as a Delivery System of Nanovaccine for Cancer Immunotherapy.

Published in:

ChemBioChem, 2025, v. 26, n. 4, p. 1, doi. 10.1002/cbic.202400857

By:

Chen, Danhong;
Ye, Xiaoyun;
Xu, Ran;
Li, Wanqiong;
Xiao, Youmei;
Niu, Xiaoshuang;
Yang, Xin;
Wang, Mengfan;
Su, Ye;
Zeng, Wenxuan;
Luo, Feiyu;
Gao, Yanfeng

Publication type:

Article

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: Interim results from 2 prospective phase 2 clinical trials.

Published in:

2013

By:

Kong, Lin;
Hu, Chaosu;
Niu, Xiaoshuang;
Zhang, Youwang;
Guo, Ye;
Tham, Ivan W K;
Lu, Jiade Jay

Publication type:

Journal Article

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma.

Published in:

Cancer (0008543X), 2013, v. 119, n. 23, p. 4111, doi. 10.1002/cncr.28324

By:

Kong, Lin;
Hu, Chaosu;
Niu, Xiaoshuang;
Zhang, Youwang;
Guo, Ye;
Tham, Ivan W. K.;
Lu, Jiade Jay

Publication type:

Article

Computer-aided design of PVR mutants with enhanced binding affinity to TIGIT.

Published in:

Cell Communication & Signaling, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12964-020-00701-y

By:

Zhou, Xiaowen;
Du, Jiangfeng;
Zhou, Xiuman;
Niu, Xiaoshuang;
Li, Wanqiong;
Chen, Chunxia;
Lv, Sifan;
Wu, Aijun;
Gou, Shanshan;
Sun, Yixuan;
Zhai, Wenjie;
Qiu, Lu;
Qi, Yuanming;
Zhao, Wenshan;
Gao, Yanfeng

Publication type:

Article

Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy.

Published in:

BMC Biology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12915-025-02132-y

By:

Zhang, Xiangrui;
Zhang, Lihan;
Li, Beibei;
Wang, Qingchao;
Chen, Peixin;
Shi, Ranran;
Zhou, Xiuman;
Niu, Xiaoshuang;
Zhai, Wenjie;
Wu, Yahong;
Shen, Wenhui;
Zhou, Xiaowen;
Zhao, Wenshan

Publication type:

Article

EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene.

Published in:

Molecular Carcinogenesis, 2017, v. 56, n. 2, p. 447, doi. 10.1002/mc.22507

By:

Huang, Yuxiang;
Wang, Xuanyi;
Niu, Xiaoshuang;
Wang, Xiaoshen;
Jiang, Rui;
Xu, Tingting;
Liu, Yong;
Liang, Liping;
Ou, Xiaomin;
Xing, Xing;
Li, Weiwei;
Hu, Chaosu

Publication type:

Article

A novel peptide targeting CCR7 inhibits tumor cell lymph node metastasis.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 5, p. 1, doi. 10.1007/s00262-025-03995-4

By:

Sun, Yixuan;
Qian, Yuzhen;
Qiu, Lu;
Zhu, Xueqin;
Ning, Haoming;
Pang, Liwei;
Niu, Xiaoshuang;
Liu, Yi;
Zhou, Xiuman;
Chen, Guanyu;
Zhai, Wenjie;
Gao, Yanfeng

Publication type:

Article

Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 3, p. 1, doi. 10.1007/s00262-025-03955-y

By:

Niu, Xiaoshuang;
Zhao, Wenshan;
Zhou, Xiuman;
Luo, Feiyu;
Xiao, Youmei;
Luo, Tao;
Sui, Xinghua;
Li, Wanqiong;
Dong, Qingyu;
Yang, Xin;
He, Zhuoying;
Shang, Wenzhi;
Sun, Yixuan;
Gao, Yanfeng

Publication type:

Article

Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 3, p. 1, doi. 10.1007/s00262-025-03955-y

By:

Niu, Xiaoshuang;
Zhao, Wenshan;
Zhou, Xiuman;
Luo, Feiyu;
Xiao, Youmei;
Luo, Tao;
Sui, Xinghua;
Li, Wanqiong;
Dong, Qingyu;
Yang, Xin;
He, Zhuoying;
Shang, Wenzhi;
Sun, Yixuan;
Gao, Yanfeng

Publication type:

Article

Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era.

Published in:

Cancer Medicine, 2024, v. 13, n. 4, p. 1, doi. 10.1002/cam4.6578

By:

Zheng, Yuming;
Xue, Fen;
Ou, Dan;
Niu, Xiaoshuang;
Hu, Chaosu;
He, Xiayun

Publication type:

Article

Dynamic Changes in Cognitive Function in Patients With Radiation-Induced Temporal Lobe Necrosis After IMRT for Nasopharyngeal Cancer.

Published in:

Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00450

By:

Liu, PeiYao;
Niu, XiaoShuang;
Ou, Dan;
Qiu, JianJian;
Lou, PengRong;
Xue, LiangJun;
Zhou, Xin;
Xu, Tingting;
Wang, XiaoShen

Publication type:

Article

LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 5661, doi. 10.2147/OTT.S207810

By:

Chu, Chu;
Niu, Xiaoshuang;
Ou, Xiaomin;
Hu, Chaosu

Publication type:

Article

Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy.

Published in:

Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01555-4

By:

Jin, Shengzhe;
Wang, Hongfei;
Li, Yang;
Yang, Jingwen;
Li, Beibei;
Shi, Peishang;
Zhang, Xiangrui;
Zhou, Xiaowen;
Zhou, Xiuman;
Niu, Xiaoshuang;
Wu, Menghan;
Wu, Yahong;
Zhai, Wenjie;
Qi, Yuanming;
Gao, Yanfeng;
Zhao, Wenshan

Publication type:

Article

Postoperative Strahlentherapie bei primär resezierbaren Desmoidtumoren im Halsbereich: eine Fallkontrollstudie.

Published in:

2019

By:

Niu, Xiaoshuang;
Jiang, Rui;
Hu, Chaosu

Publication type:

journal article

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.801090

By:

Xue, Fen;
Niu, Xiaoshuang;
Hu, Chaosu;
He, Xiayun

Publication type:

Article

Pretreatment FDG PET in prognosis of locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.

Published in:

International Journal of Medical Sciences, 2025, v. 22, n. 4, p. 933, doi. 10.7150/ijms.105995

By:

Xiaoshuang Niu;
Fen Xue;
Dan Ou;
Yuming Zheng;
Chaosu Hu;
Chunying Shen;
Xiayun He

Publication type:

Article

Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era.

Published in:

International Journal of Medical Sciences, 2022, v. 19, n. 2, p. 267, doi. 10.7150/ijms.68394

By:

Xiaoshuang Niu;
Fen Xue;
Peiyao Liu;
Chaosu Hu;
Xiayun He

Publication type:

Article

Long-term results of locoregionally advanced nasopharyngeal carcinoma treated with cisplatin and 5-fluorouracil induction chemotherapy with or without docetaxel in young and middle aged adults.

Published in:

Journal of Cancer Research & Clinical Oncology, 2025, v. 151, n. 3, p. 1, doi. 10.1007/s00432-025-06145-6

By:

Zheng, Yuming;
Xue, Fen;
Ou, Dan;
Niu, Xiaoshuang;
Hu, Chaosu;
He, Xiayun

Publication type:

Article

Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 6, p. 1063, doi. 10.1007/s00432-013-1419-z

By:

Niu, Xiaoshuang;
Hu, Chaosu;
Kong, Lin

Publication type:

Article

Radiotherapy in the treatment of primary or recurrent unresectable desmoid tumors of the neck.

Published in:

2019

By:

Niu, Xiaoshuang;
Jiang, Rui;
Hu, Chaosu

Publication type:

journal article

Is Immune Therapy Plus Chemotherapy More Effective Than Immune Therapy Alone for Unresectable Recurrent Nasopharyngeal Carcinoma?

Published in:

Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.762663

By:

Zhou, Xin;
Niu, XiaoShuang;
Liu, PeiYao;
Ou, Dan;
Zhu, Yi;
Wang, XiaoShen

Publication type:

Article